BRTX

BioRestorative Therapies, Inc.

Nasdaq· Services-Misc Health & Allied Services, NEC· Inc. NV· CIK 0001505497 Healthcare & Medical Devices

$1.58 −0.04 (−2.47%)

Oct 26 4:00 PM ET · prev $1.62

Market cap

$2.1M

Nano cap

Consensus

Buy

88% Buy or better · 8 analysts

Median target

$300.00

+18887% · range $300.00–300.00

Next earnings

Nov 10

in 15 days · EPS est. −$3.00

1 year

−0.6%

from $1.59 · Oct 27

30 days

−31.6%

from $2.31

52-week range

$0.1437–4.94

−68% from high · low Sep 3

Avg volume 20D

31.8K

Oct 8 spike 95.6K

Short interest

13.2K

≈0.9% of shares · +13.5%

Days to cover

1.0

at average volume

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BEARISH 4 reports · 90 days

Balance 2 bearish · 0 bullish · 2 neutral oldest → newest, height = score

Avg score

·High conf. 3/4 ·Next Earnings date, Nov 10, 2026

Strongest BEARISH BioRestorative Therapies' VP of R&D, Mr. Silva, resigned effective immediately on September 4, 2026…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

X Aug 14 Short interest falls 78.5% to 99.7K
R Aug 25 BioRestorative Therapies received a Nasdaq delinquency notice for fa…
X Aug 31 Short interest falls 62.2% to 37.6K
E Sep 2 FDA: BioRestorative Therapies Announces Reverse Stock Split
E Sep 4 Trading halt: Trading Halt: BRTX — T1 (News Pending)
R Sep 11 BioRestorative Therapies' VP of R&D, Mr. Silva, resigned effective i…
X Sep 15 Short interest falls 69.2% to 11.6K
A Oct 6 Maxim Group downgrades

Signal stack

Where each data set points today.

InstitutionsMIXED

Q2 2026: 1 added (0 new), 2 trimmed or exited.
AnalystsBULLISH

7 of 8 rate it Buy or better. Every target is above the price.
Short sellersSTEADY

Short interest +13.5% to 13.2K shares. 1.0 days to cover, ≈0.9% of shares.
TrendRANGE

3% above its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
UBS Group AG	NEAR_EXIT	1	—
VANGUARD FIDUCIARY TRUST CO	DOUBLED	181,300	$68.2K
GEODE CAPITAL MANAGEMENT, LLC	TRIM	152,417	$57.3K
GEODE CAPITAL MANAGEMENT, LLC	DOUBLED	223,083	$60.7K
STATE STREET CORP	ADD	32,459	$38.0K
VANGUARD GROUP INC	DOUBLED	88,778	$127.0K
UBS Group AG	NEAR_EXIT	3	$5.00
MORGAN STANLEY	ADD	38,000	$67.6K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

8 analysts

Buy 88% rate it Buy or better

Strong Buy2Buy5Hold1Sell0Strong Sell0

12-month targets · 1 analysts

$1.58 $300.00 $300.00 $300.00

Price is below the lowest target. Median implies +18887%.Targets as of Oct 26, 2026.

Recent actions

Date	Firm	Action	Rating
Oct 6, 2026	Maxim Group DOWNGRADE	DOWNGRADE	Hold

Earnings setup

Estimates

Nov 10

reports in 15 days

−$3.00

EPS estimate, this quarter

1↑ 0↓

revisions, 30 days

Current-quarter EPS estimate

$0.000

90d

$0.000

60d

−$5.000

30d

−$5.000

−$3.000

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$3.00	-$3.00–-$3.00	+40.0%	$70.0K
Next Q	-$2.60	-$2.60–-$2.60	+43.5%	$90.0K
Current FY	-$13.20	-$13.20–-$13.20	+43.6%	$310.0K
Next FY	-$10.40	-$10.40–-$10.40	+46.4%	$1.5M